BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34037228)

  • 1. Socioeconomic position and first-time major cardiovascular event in patients with type 2 diabetes: a Danish nationwide cohort study.
    Falkentoft AC; Zareini B; Andersen J; Wichmand C; Hansen TB; Selmer C; Schou M; Gæde PH; Staehr PB; Hlatky MA; Torp-Pedersen C; Gislason GH; Gerds TA; Bruun NE; Ruwald AC
    Eur J Prev Cardiol; 2022 Jan; 28(16):1819-1828. PubMed ID: 34037228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study.
    Kristensen FPB; Christensen DH; Mortensen MB; Maeng M; Kahlert J; Sørensen HT; Thomsen RW
    Cardiovasc Diabetol; 2023 Jul; 22(1):187. PubMed ID: 37495999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
    Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
    J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of radial pulse spectrum on the risk of major adverse cardiovascular events in patients with type 2 diabetes.
    Chang CW; Liao KM; Chang YT; Wang SH; Chen YC; Wang GC
    J Diabetes Complications; 2019 Feb; 33(2):160-164. PubMed ID: 30381150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?
    Malmborg M; Schmiegelow MDS; Nørgaard CH; Munch A; Gerds T; Schou M; Kistorp C; Torp-Pedersen C; Hlatky MA; Gislason G
    Eur Heart J; 2020 Apr; 41(13):1346-1353. PubMed ID: 31860067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albuminuria and Risk of Cardiovascular Events and Mortality in a General Population of Patients with Type 2 Diabetes Without Cardiovascular Disease: A Danish Cohort Study.
    Fangel MV; Nielsen PB; Kristensen JK; Larsen TB; Overvad TF; Lip GY; Jensen MB
    Am J Med; 2020 Jun; 133(6):e269-e279. PubMed ID: 32205071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes.
    Nowak C; Carlsson AC; Östgren CJ; Nyström FH; Alam M; Feldreich T; Sundström J; Carrero JJ; Leppert J; Hedberg P; Henriksen E; Cordeiro AC; Giedraitis V; Lind L; Ingelsson E; Fall T; Ärnlöv J
    Diabetologia; 2018 Aug; 61(8):1748-1757. PubMed ID: 29796748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of first-time major cardiovascular event among individuals with newly diagnosed type 2 diabetes: data from Danish registers.
    Falkentoft AC; Gerds TA; Zareini B; Knop FK; Køber L; Torp-Pedersen C; Schou M; Bruun NE; Ruwald AC
    Diabetologia; 2023 Nov; 66(11):2017-2029. PubMed ID: 37528178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal changes in risk of cardiovascular events in people with newly diagnosed type 2 diabetes with and without cardiovascular disease.
    Nørgaard CH; Starkopf L; Gerds TA; Malmborg M; Bonde AN; Zareini B; Mills EHA; Vestergaard P; Wong ND; Torp-Pedersen C; Lee CJ
    J Diabetes Complications; 2022 Feb; 36(2):108126. PubMed ID: 35033442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic position and one-year mortality risk among patients with heart failure: A nationwide register-based cohort study.
    Andersen J; Gerds TA; Gislason G; Schou M; Torp-Pedersen C; Hlatky MA; Møller S; Madelaire C; Strandberg-Larsen K
    Eur J Prev Cardiol; 2020 Jan; 27(1):79-88. PubMed ID: 31349771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low-Risk Population With Type 2 Diabetes Mellitus.
    Malmborg M; Schmiegelow MDS; Gerds T; Schou M; Kistorp C; Torp-Pedersen C; Gislason G
    J Am Heart Assoc; 2021 Jul; 10(13):e020395. PubMed ID: 34151606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of Cardiovascular Autonomic Neuropathy Is a Predictor Associated With Major Adverse Cardiovascular Events in Adults With Type 2 Diabetes Mellitus: A 6-Year Follow-up Study.
    Lai YR; Huang CC; Chang HW; Chiu WC; Tsai NW; Cheng BC; Chen JF; Lu CH
    Can J Diabetes; 2021 Mar; 45(2):155-161. PubMed ID: 33046397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study.
    Kawabe A; Yasu T; Morimoto T; Tokushige A; Momomura SI; Sakakura K; Node K; Inoue T; Ueda S;
    ESC Heart Fail; 2021 Oct; 8(5):3748-3759. PubMed ID: 34268904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Events, Acute Hospitalizations, and Mortality in Patients With Type 2 Diabetes Mellitus Who Initiate Empagliflozin Versus Liraglutide: A Comparative Effectiveness Study.
    Thomsen RW; Knudsen JS; Kahlert J; Baggesen LM; Lajer M; Holmgaard PH; Vedin O; Ustyugova A; Sørensen HT
    J Am Heart Assoc; 2021 Jun; 10(11):e019356. PubMed ID: 34032121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in Cardiovascular Disease Risk Factor Prevalence, Morbidity, and Mortality in Colombia: Findings from the Prospective Urban Rural Epidemiology (PURE) Study.
    Lopez-Lopez JP; Toro MR; Martinez-Bello D; Garcia-Peña ÁA; O'Donovan G; Perez-Mayorga M; Otero J; Rangarajan S; Yusuf S; Lopez-Jaramillo P
    Glob Heart; 2024; 19(1):10. PubMed ID: 38273994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients.
    Gellen B; Thorin-Trescases N; Sosner P; Gand E; Saulnier PJ; Ragot S; Fraty M; Laugier S; Ducrocq G; Montaigne D; Llaty P; Rigalleau V; Zaoui P; Halimi JM; Roussel R; Thorin E; Hadjadj S
    Diabetologia; 2016 Nov; 59(11):2321-2330. PubMed ID: 27491833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.
    Thein D; Christiansen MN; Mogensen UM; Bundgaard JS; Rørth R; Madelaire C; Fosbøl EL; Schou M; Torp-Pedersen C; Gislason G; Køber L; Kristensen SL
    Cardiovasc Diabetol; 2020 Jul; 19(1):107. PubMed ID: 32631337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends in socioeconomic disparity in clinical outcomes for patients with acute coronary syndrome.
    Simoni AH; Valentin JB; Kragholm KH; Bøggild H; Jensen SE; Johnsen SP
    Cardiovasc Revasc Med; 2023 Nov; 56():64-72. PubMed ID: 37258374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.